Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AK3280 Cream After Cicatrectomy in Patients With Hypertrophic Scar
NCT05434897Phase 2Completed
- Sponsor
- Ark Biosciences
- Start
- Jul 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AK3280 Cream in Hypertrophic Scar (HS), sponsored by Ark Biosciences. Started Jul 2022; status: completed.
02
Drugs
AK3280 Cream
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on NCT05434897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05434897.